Tumor tissue from 21 participants (75%) contained an adequate number of tumor cells to be evaluable for expression of CD200, and 12 of the 21 (57%) had detectable tumor cell CD200 expression (CD200 H-score > 0, assay range 0–300). The gene discussed is CD200; the disease is neoplasm.